Published in J Infect on October 01, 2001
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev (2003) 2.90
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood (2006) 1.83
K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis. PLoS One (2007) 1.11
Human herpesvirus 8--a novel human pathogen. Virol J (2005) 1.00
KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res (2014) 0.99
Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer (2005) 0.95
Kaposi's Sarcoma after Kidney Transplantation: a 21-Years Experience. Int J Hematol Oncol Stem Cell Res (2013) 0.94
Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol (2007) 0.88
Structure of the opening reading frame 49 protein encoded by Kaposi's sarcoma associated herpesvirus (KSHV). J Virol (2016) 0.75
Confirming high prevalence of human herpesvirus 8 infection in chronic kidney disease patients in São Paulo, Brazil. NDT Plus (2009) 0.75
KSHV and the Role of Notch Receptor Dysregulation in Disease Progression. Pathogens (2017) 0.75
Synthetic maps of human gene frequencies in Europeans. Science (1978) 10.35
Y chromosome sequence variation and the history of human populations. Nat Genet (2000) 8.34
Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data. Proc Natl Acad Sci U S A (1988) 6.72
The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science (1987) 6.16
Demic expansions and human evolution. Science (1993) 5.59
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet (1994) 5.49
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science (1990) 4.28
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J (2010) 3.81
Biologically diverse molecular variants within a single HIV-1 isolate. Nature (1988) 3.80
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant (2007) 3.26
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J (2009) 3.16
Multiple DNA fragment polymorphisms associated with immunoglobulin mu chain switch-like regions in man. Proc Natl Acad Sci U S A (1983) 3.07
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med (1999) 2.78
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol (1997) 2.59
Uralic genes in Europe. Am J Phys Anthropol (1990) 2.57
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Association between hepatitis E virus and HIV infection in homosexual men. Lancet (1994) 2.49
High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet (1985) 2.44
Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group. Arch Intern Med (1998) 2.38
XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis (2001) 2.35
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science (1988) 2.30
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst (1999) 2.18
Analysis of evolution: evolutionary rates, independence and treeness. Theor Popul Biol (1975) 2.15
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood (1999) 2.10
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J (2009) 2.07
Biology of Kaposi's sarcoma. Eur J Cancer (2001) 2.07
Chikungunya in north-eastern Italy: a summing up of the outbreak. Euro Surveill (2007) 2.07
AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology (2000) 2.05
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science (2000) 2.03
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst (1999) 2.01
Complete clinical remission of psoriasis 6 months after renal transplantation. Transplant Proc (2013) 2.01
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol (1992) 1.97
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature (1989) 1.96
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature (1987) 1.93
Statistical methods for assessing linkage disequilibrium at the HLA-A, B, C loci. Ann Hum Genet (1981) 1.93
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A (1993) 1.93
Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998. Lazio AIDS Surveillance Collaborative Group. AIDS (1999) 1.92
High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS (1996) 1.92
An outbreak of chikungunya fever in the province of Ravenna, Italy. Euro Surveill (2007) 1.81
Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med (1998) 1.79
Immune responses to AAV in a phase I study for Canavan disease. J Gene Med (2006) 1.74
Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer (1997) 1.73
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis (1997) 1.69
Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69
HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci U S A (1996) 1.67
Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A (1995) 1.64
The Fifth Histocompatibility Workshop gene frequency data: a phylogenetic analysis. Tissue Antigens (1975) 1.64
Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health (2008) 1.61
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther (2003) 1.60
How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS) J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.57
Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus type 1 testing program. Sex Transm Dis (1997) 1.57
Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet (1993) 1.56
Probable autochthonous introduced malaria cases in Italy in 2009-2011 and the risk of local vector-borne transmission. Euro Surveill (2012) 1.54
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation (2001) 1.53
The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J (2001) 1.53
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients. Aliment Pharmacol Ther (2009) 1.49
DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer (2001) 1.48
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet (1996) 1.43
Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest (1995) 1.43
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant (2012) 1.42
Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol (2005) 1.42
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol (1992) 1.42
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study. AIDS (2001) 1.41
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome. Hepatol Int (2014) 1.41
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation. Ital J Gastroenterol Hepatol (1999) 1.39
Synthetic gene frequency maps of man and selective effects of climate. Proc Natl Acad Sci U S A (1981) 1.39